济宁治疗癫痫好的医院是哪滨州有没有治疗癫痫的好医院,枣庄中医能否治疗羊羔疯,菏泽癫痫治疗需要多少钱,日照儿童癫痫疾病怎么治疗,淄博最专业的治儿童医院羊羔疯专病,济南癫痫病医院疗法,威海大型羊癫疯病医院

SAN DIEGO (KGTV) — A medical helicopter transporting a heart from Grossmont Hospital for transplant crashed on the helipad of a Los Angeles-area hospital on Friday.The AgustaWestland A109 medical helicopter flipped onto its side after experiencing a hard landing on the roof of Keck Hospital of USC at about 3:15 p.m., according to a statement from the hospital. Three people on board, the pilot and two medical personnel, escaped without major injuries. Nobody on the ground or in the hospital was injured, the hospital and FAA said. Patient care at the hospital was not interrupted.The helicopter was carrying a heart from Sharp Grossmont Hospital in La Mesa, according to helicopter service provider Helinet. The hospital said in a statement that the organ was safely delivered to the intended patient in time for surgery.“We are fully cooperating with the NTSB and FAA on their investigations,” said Helinet COO and President Sean M. Cross. “Our company prides itself on professional operation and maintenance of aircraft as core values - the safety of our customers and pilots is always our top priority. We are happy that at this time there appear to have been no serious injuries.”The FAA and National Transportation Safety Board are investigating the crash.Helinet says it completed more than 1,300 helicopter air ambulance missions in 2019. Company officials are also on-site assisting in the investigation. 1424

SAN DIEGO (KGTV) — A repeat DUI offender who pleaded guilty to hitting and killing a tow-truck operator on SR-52 in 2017 has been sentenced.Michael Gilbert Gray, 50, pleaded guilty to second-degree murder in August in the death of 55-year-old Fred Griffith.Gray was sentenced Friday to 25 years to life in prison.On Feb. 23, 2017, Griffith, a single father of three, was aiding a stranded trash truck on the freeway near Tierrasanta when he was struck and killed by Gray's Ford Expedition.RELATED 514

SAN DIEGO (KGTV) -- A judge has ruled that the government can continue waiving environmental laws to proceed with construction of a U.S.-Mexico border wall.Judge Gonzalo Curiel issued the ruling Tuesday afternoon. The ruling allows 14 miles of border wall to be built southeast of San Diego.The ruling comes one day after the Washington Post reported that President Trump will visit border wall prototypes in mid-March. RELATED: President Trump to visit San Diego, inspect border wall prototypesIn early February, ABC News reported that the Center for Biological Diversity filed a lawsuit against the U.S. Department of Homeland Security to protect endangered butterflies. Environmentalists claim the Quino checkerspot butterfly and a number of other species could be in danger if construction of the border wall continues. “We intend to appeal this disappointing ruling, which would allow Trump to shrug off crucial environmental laws that protect people and wildlife,” said Brian Segee, a senior attorney at the Center for Biological Diversity.“The Trump administration has completely overreached its authority in its rush to build this destructive, senseless wall. They’re giving unprecedented, sweeping power to an unelected agency chief to ignore dozens of laws and crash through hundreds of miles of spectacular borderlands. This is unconstitutional and shouldn’t be allowed to stand.”RELATED: San Diego federal judge fails to make ruling over border wall lawsuitCalifornia Attorney General Xavier Becerra said in a statement Tuesday afternoon that "A medieval wall along the U.S.-Mexico border simply does not belong in the 21st century.”Read the full statement below:“We remain unwavering in our belief that the Trump Administration is ignoring laws it doesn’t like in order to resuscitate a campaign talking point of building a wall on our southern border. We will evaluate all of our options and are prepared to do what is necessary to protect our people, our values, and our economy from federal overreach. A medieval wall along the U.S.-Mexico border simply does not belong in the 21st century.” 2170

SAN DIEGO (KGTV) -- A San Diego man died after crashing his car into a ditch overnight Sunday, according to the California Highway Patrol. The crash happened on I-5 north near Clairemont in East Mission Bay. Officers say they believe the single-vehicle crash happened sometime overnight, but wasn't reported until the sun came up. According to CHP, the car crashed into a ditch on the side of a freeway. Officers say it's too early to determine if drugs or alcohol were involved in the crash.  521

SAN DIEGO (KGTV) -- A San Diego biotech is developing a device that could change how people get routine blood tests.Truvian, which moved into its new UTC area headquarters Thursday, is developing a product that could deliver 40 routine results within 20 minutes, requiring just five drops of blood. The company's chief executive says it should cost less than . "We're going to give you those results in 20 minutes, and it will cost you or your insurance a fraction of what you're paying today," said Jeff Hawkins, CEO of Truvian. RELATED: Biotech industry is booming, hiring and attainable for anyoneThe company has 50 employees working to develop the system, which it plans to submit to the Food and Drug Administration next year. Hawkins said the idea is to get the product into retail clinics like at CVS, Walgreen's and Walmart, plus private and corporate clinics. Kim Kamdar, a co-founder, said it will allow patients to get their clinical chemistry, immunoassays and hematology, which cover the range of routine blood work. Truvian's announcement comes about a year after Theranos shut down in disgrace. Theranos promised hundreds of results from a single drop of blood, but investigations uncovered fraudulent claims. Now, its founder Elizabeth Holmes and former president Ramesh "Sunny" Balwani face criminal charges. Hawkins said Truvian is different because it knows its limits. RELATED: Biotech fields seek veterans for jobs"We, from day one, got advisors who are clinicians, who are laboratory medicine specialists, who work in academia, who work in hospitals everyday, to be the people who are critiquing our work," he said. "We wanted to surround ourselves with people who would critique our work and make sure we are hitting the bar that's needed."Truvian plans to hire 30 people in the coming year. If all goes as planned, Truvian's system could hit the U.S. market by mid 2021. 1906